The Intersection of Biotechnology and Health Issues in IP Law: RIPL's Special Issue 2011
Par :Formats :
Disponible dans votre compte client Decitre ou Furet du Nord dès validation de votre commande. Le format ePub est :
- Compatible avec une lecture sur My Vivlio (smartphone, tablette, ordinateur)
- Compatible avec une lecture sur liseuses Vivlio
- Pour les liseuses autres que Vivlio, vous devez utiliser le logiciel Adobe Digital Edition. Non compatible avec la lecture sur les liseuses Kindle, Remarkable et Sony
, qui est-ce ?Notre partenaire de plateforme de lecture numérique où vous retrouverez l'ensemble de vos ebooks gratuitement
Pour en savoir plus sur nos ebooks, consultez notre aide en ligne ici
C'est si simple ! Lisez votre ebook avec l'app Vivlio sur votre tablette, mobile ou ordinateur :
- FormatePub
- ISBN978-1-61027-076-2
- EAN9781610270762
- Date de parution02/01/2014
- Protection num.pas de protection
- Infos supplémentairesepub
- ÉditeurMark Childress
Résumé
One of the leading IP law journals in the world presents it second special symposium issue to go ebook (the 2010 issue, available as well, centered on the "green" movement and its intellectual property law issues). This edition of John Marshall RIPL is the new 2011 Special Issue, with seven cutting-edge articles from recognized lawyers and scholars of IP law and biotechnology and health sciences. Each spring, RIPL produces a symposium law review issue.
In this important contribution, RIPL presents very current articles on emerging biotech research and industries, and their promotion through IP law, including patents and trademarks. Topics include encouraging biotech innovation through patent protection, the risks and advantages of DIY scientists, plain packaging of tobacco, research funding of small projects, the materiality doctrine for inequitable conduct, patenting genetic materials, EU law on patent infringement, and health care reform's effect on drug research.
The volume is also useful and accessible to non-lawyers interested in these issues and the way they are affected by legal and policy decisions.
In this important contribution, RIPL presents very current articles on emerging biotech research and industries, and their promotion through IP law, including patents and trademarks. Topics include encouraging biotech innovation through patent protection, the risks and advantages of DIY scientists, plain packaging of tobacco, research funding of small projects, the materiality doctrine for inequitable conduct, patenting genetic materials, EU law on patent infringement, and health care reform's effect on drug research.
The volume is also useful and accessible to non-lawyers interested in these issues and the way they are affected by legal and policy decisions.
One of the leading IP law journals in the world presents it second special symposium issue to go ebook (the 2010 issue, available as well, centered on the "green" movement and its intellectual property law issues). This edition of John Marshall RIPL is the new 2011 Special Issue, with seven cutting-edge articles from recognized lawyers and scholars of IP law and biotechnology and health sciences. Each spring, RIPL produces a symposium law review issue.
In this important contribution, RIPL presents very current articles on emerging biotech research and industries, and their promotion through IP law, including patents and trademarks. Topics include encouraging biotech innovation through patent protection, the risks and advantages of DIY scientists, plain packaging of tobacco, research funding of small projects, the materiality doctrine for inequitable conduct, patenting genetic materials, EU law on patent infringement, and health care reform's effect on drug research.
The volume is also useful and accessible to non-lawyers interested in these issues and the way they are affected by legal and policy decisions.
In this important contribution, RIPL presents very current articles on emerging biotech research and industries, and their promotion through IP law, including patents and trademarks. Topics include encouraging biotech innovation through patent protection, the risks and advantages of DIY scientists, plain packaging of tobacco, research funding of small projects, the materiality doctrine for inequitable conduct, patenting genetic materials, EU law on patent infringement, and health care reform's effect on drug research.
The volume is also useful and accessible to non-lawyers interested in these issues and the way they are affected by legal and policy decisions.
